Trump's Contrarian Silicon Valley Supporters
Donald
Trump's Contrarian Silicon Valley Supporters
Donald Trump has few supporters in liberal Silicon Valley -- even Peter Thiel, the PayPal co-founder and Facebook board member, who spoke for the Republican nominee at the Republican National Convention, hasn't given a cent to the campaign. Yet the tech world doesn't unanimously favor Democrats.
Consider, for example, the financial support that Oculus founder Palmer Luckey has given to a pro-Trump trolling campaign. Luckey, 24, sold his virtual reality startup to Facebook for $2 billion after Oculus became a crowdfunding star. He has confirmed to the Daily Beast that he's donated money to a group called Nimble America to produce memes and negative posts about Hillary Clinton. Nimble America also put up a billboard outside Pittsburgh with a large image of Clinton's face and the legend, "Too Big to Jail." Luckey explained that he'd met the meme-makers behind the group on Facebook and offered them money because he "would love to see more of that stuff." It's this kind of surprising support that has made Trump a strong contender for the presidency
Nimble America was set up by two moderators of the r/The_Donald thread on Reddit, which is full of not just anti-Clinton, but also anti-immigrant and outright racist memes. Luckey made it sound as if he just enjoyed the trolling as "a real jolly good time." That would ring hollow to Amazon founder Jeff Bezos, who offered to launch Trump into outer space after the candidate lashed out at him as the owner of The Washington Post. Tim Cook, the chief executive of Apple, wouldn't see it the same as Luckey either: He withdrew Apple's support for the Republican National Convention this year after Trump called for a boycott of Apple products because of the company's reluctance to help U.S. law enforcement decrypt a terrorist's iPhone.
The Silicon Valley has long leaned Democratic or even further left. This year, the most typical donor of the Green Party candidate Jill Stein is a male software engineer from California, according to Crowdpac, an organization that analyzes political donation data. Trump's right-wing views are unappealing to this constituency. A group of tech executives and venture capitalists, including Apple co-founder Steve Wozniak and a few other important names in the industry, published a strongly-worded anti-Trump letter in July. Trump hasn't been nice to the Valley's aristocracy such as Bezos and Cook, and they have no reason to back him. According to data from Crowdpac, the technology industry has donated all of $225,000 to the Trump campaign.
Clinton has collected $6.1 million from tech donors, according to Crowdpac, out of her total of $510 million. Barack Obama had did better with tech workers in both of his presidential campaigns.
Neither Thiel nor Luckey has described himself as a hardcore Trump fan. The PayPal co-founder is a libertarian who believes that an increasingly incompetent government has run down the economy. Luckey claims to be a believer in politically incorrect fun. It's not easy to find people in tech who would be against trade or immigration as Trump says he is: The industry wins from both. Those who back the billionaire do so out of contrariness, the spirit of disruption and rebellion that is as important to Silicon Valley's soul as social liberalism.
The rare open Trump backers are not so much pro-Trump as anti-Clinton. To them, she stands for the bland, faceless status quo; Thiel says that the U.S. needs to be "rebuilt" and that Clinton would be a one-term president because she'd drive the economy into a new crisis. Luckey, in one of his Reddit posts as "NimbleRichMan," wrote of "fighting the American elite."
This doesn't present any serious danger to Clinton in Silicon Valley, where polls show she has more than double Trump's support. It's just that the backing, at least initially, was less enthusiastic than for Obama, and techies' belief that she can shake things up and bring positive change is weaker than it was with the outgoing president. That's a bad sign for her nationwide. So is the departure from their peers of Thiel and Luckey: The U.S. is at least partly built on the same contrarian spirit that drives these two successful startup founders, and it can outweigh many voters' distaste for the Republican's views.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...
Continue Reading
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Top 5 Most Recently Viewed Articles
ANI Pharmaceuticals Set for Key Presentation at Biotech Conference ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is gearing up to showcase its advancements at the Guggenheim Biotech Conference. On an exciting date, Nikhil Lalwani, the Company’s President and CEO, along with Stephen Carey, the CFO, will host a fireside chat to discuss the latest developments and future plans...
Continue Reading
Reviving the North Shore Economy, One Shuttle Ride at a Time Not every day do you see a $5 investment with such community punch. On June 29, a new bus service launches, whisking folks from Waik?k? and Ko Olina to O?ahu’s North Shore. But this ain't just another tourist bus ride—it's a lifeline for local businesses hit hard by March's kona low storms. Connecting...
Continue Reading
Virginia Cancer Specialists Expands its Reach with a New Center Virginia Cancer Specialists, a leading private cancer practice in the region, has announced the opening of their newly expanded cancer center. This important development aims to enhance patient care and provide access to the latest cancer treatments. The expansion not only signifies growth but also a...
Continue Reading
Important Financial Calendar for TCM Group A/S TCM Group A/S is a significant player in the kitchen and furniture manufacturing industry. As the year approaches its end, the company has established key dates for reporting and annual meetings, signaling to shareholders and stakeholders the importance of staying informed. Scheduled Report Releases and Meetings The Board of...
Continue Reading
Understanding the Recent Chicago PMI Decline Recently, the Chicago Purchasing Managers' Index (PMI) reported a surprising score of 36.9, highlighting ongoing challenges in the manufacturing sector within the region. This score is a clear indication that the manufacturing landscape in Chicago is experiencing significant contraction, a worrisome sign for the local and...
Continue Reading